Humanized antibodies against CXCR3

Details for Australian Patent Application No. 2008210589 (hide)

Owner Teva Biopharmaceuticals USA, Inc.

Inventors Smith, Rodger; Roschke, Viktor; Kanakaraj, Palanisamy

Agent Griffith Hack

Pub. Number AU-A-2008210589

PCT Pub. Number WO2008/094942

Priority 60/898,709 01.02.07 US

Filing date 29 January 2008

Wipo publication date 7 August 2008

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

20 August 2009 PCT application entered the National Phase

  PCT publication WO2008/094942 Priority application(s): WO2008/094942

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008210637-Benzylamine derivative or pharmaceutically acceptable acid addition salt thereof, and use thereof for medical purposes

2008210586-Use of chromium histidinate for treatment of cardiometabolic disorders